|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits at other financial institutions | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Available for sale securities, at fair value | ||||||||||||||||||||
| Fair Value | ||||||||||||||||||||
| Loans held for investment | ||||||||||||||||||||
| Less: allowance for credit losses on loans | ||||||||||||||||||||
| Loans, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Federal Home Loan Bank stock | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Core deposit intangibles, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Demand | ||||||||||||||||||||
| Money market and savings | ||||||||||||||||||||
| Certificates and other time | ||||||||||||||||||||
| Total interest-bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Borrowed funds | ||||||||||||||||||||
| Subordinated debt | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| COMMITMENTS AND CONTINGENCIES (See Note 13) | ||||||||||||||||||||
| SHAREHOLDERS’ EQUITY: | ||||||||||||||||||||
| Preferred stock, $1 par value; 1,000,000 shares authorized; no shares issued or outstanding | ||||||||||||||||||||
| Common stock, $1 par value; 80,000,000 shares authorized; 20,154,284 shares issued and outstanding at June 30, 2022 and 20,337,220 shares issued and outstanding at December 31, 2021 | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY |
Loading...
